We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Teligent Inc | NASDAQ:TLGT | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.1735 | 0.1721 | 0.1744 | 0 | 01:00:00 |
From May 2019 to May 2024
BUENA, N.J., April 21, 2017 /PRNewswire/ -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:15 pm ET on Tuesday, May 2, 2017 to discuss the 1st quarter 2017 results.
The Company invites you to listen to the call by dialing 1-888-346-3479. International participants should call 1-412-902-4260. Canadian participants should call 1-855-669-9657. Participants should ask to be joined into the Teligent, Inc. call.
This call is being webcast by MultiVu (a PR Newswire Company) and can be accessed in the Investor Relations Section of Teligent Inc.'s website at www.teligent.com.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
|
Contact: |
Jenniffer Collins |
|
Teligent, Inc. | |
|
(856) 697-4379 | |
|
www.teligent.com |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/teligent-inc-to-hold-conference-call-for-1st-quarter-2017-results-300443032.html
SOURCE Teligent, Inc.
Copyright 2017 PR Newswire
1 Year Teligent Chart |
1 Month Teligent Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
